Question follow-through · 98764
Asthma: Diagnosis
To ask the Secretary of State for Health and Social Care, whether his Department plans to expand fractional exhaled Nitric Oxide (FeNO) testing for asthma diagnosis.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Dec 2025
- Target answer date
- 15 Dec 2025
- Answer
- 14 Jan 2026 · 35 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Multiple Sclerosis: Northern Ireland · 15 Dec 2025
- Multiple Sclerosis: Women · 15 Dec 2025
- Chronic Obstructive Pulmonary Disease · 15 Dec 2025
- Chronic Obstructive Pulmonary Disease: Health Services · 15 Dec 2025
- Prostate Cancer: Screening · 15 Dec 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Dec 2025
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department plans to expand fractional exhaled Nitric Oxide (FeNO) testing for asthma diagnosis.
15 Dec 2025
Target answer date
Date supplied by the official written-questions record.
14 Jan 2026
Answer published
The Department is committed to improving access to fractional exhaled nitric oxide (FeNO) testing.FeNO testing is a recommended core test for any standard community diagnostic centre (CDC). Currently 112 CDC sites in England offer FeNO testing.In November...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Multiple Sclerosis: Northern Ireland
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what discussions he has had with the Northern Ireland Department of Health on the application of learning from the NHS England Neurology Transformation Programme to improve access to specialised ne
Multiple Sclerosis: Women
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what plans his Department has to address multiple sclerosis in the updated Women’s Health Strategy; and whether there will be discussions on how this can inform development of the Northern Ireland
Chronic Obstructive Pulmonary Disease
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, how admissions for chronic obstructive pulmonary disease have changed since the start of the winter season; and what geographical variation there has been in those admissions.
Chronic Obstructive Pulmonary Disease: Health Services
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, how many referrals have been made for chronic obstructive pulmonary disease as part of the Targeted Lung Health Checks programme; and what regional variation there has been in chronic obstructive p
Prostate Cancer: Screening
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the UK National Screening Committee’s draft recommendation on prostate cancer screening on future demand for PSMA PET-CT imaging,
Prostate Cancer: Screening
15 Dec 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help avoid creating a single point of failure in PET-CT diagnostic services.
Prostate Cancer: Screening
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has been made of the adequacy of national production capacity for PSMA radiotracers in the context of projected clinical demand for prostate cancer diagnosis.
Prostate Cancer: Screening
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of levels of access to PSMA PET-CT imaging on regional and ethnic inequalities in prostate cancer diagnosis and outcomes.
Prostate Cancer: Screening
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of changes to PET-CT procurement in England on diagnostic access for patients from Northern Ireland who rely on specialist capacity e
Asthma: Drugs
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of (a) trends in the level of variation in access to NICE-recommended biologic medicines for severe asthma.
Asthma: Drugs
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has reviewed the rate of uptake of biologic medicines for severe asthma relative to the eligible population.
Asthma and Chronic Obstructive Pulmonary Disease: Health Services
16 Dec 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the proportion of patients with asthma and chronic obstructive pulmonary disease receiving annual reviews.